Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc - Seite 4
Investor Relations Contact:
Endonovo Therapeutics, Inc.
Steve Barnes
sbarnes@endonovo.com
www.endonovo.com